Cognition Studio, Inc.

Kartos Therapeutics Website Visual 

Prev Next
Previous

SARS-CoV-2 Close-up View of the Spike Protein

medical illustration of Kartos Therapeutics is dedicated to developing novel, targeted therapeutics that meaningfully improve cancer patients' lives. To explain its selective oral MDM2 inhibitor, navtemadlin, Kartos partnered with Cognition on a website refresh, which utilized vibrant, scientifically credible high-level 3D static visualizations of various biological processes involved in its research.
Next medical animation of Omega’s groundbreaking platform of epigenomic programming and precision gene control focuses on the insulated genomic domain (IGD), a relatively unfamiliar biological structure. By showing where they’re located, and how different types of disruptions in them can contribute to the gene under/overexpression and thus disease, this animation presents Omega’s ability to map and identify specific IGD targets computationally and create Omega Epigenomic Controllers to potentially restore IGD structures.

Omega: Epigenomic Programming MOA

Kartos Therapeutics is dedicated to developing novel, targeted therapeutics that meaningfully improve cancer patients' lives. To explain its selective oral MDM2 inhibitor, navtemadlin, Kartos partnered with Cognition on a website refresh, which utilized vibrant, scientifically credible high-level 3D static visualizations of various biological processes involved in its research.

Keywords: 3D, Advertising / Marketing, Web, Biology, Biotechnology, Cell biology / Histology, Molecular Biology, Oncology

Kartos Therapeutics